Comerica Securities Inc. boosted its stake in Mettler-Toledo International Inc. (NYSE:MTD) by 48.6% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 670 shares of the medical instruments supplier’s stock after buying an additional 219 shares during the period. Comerica Securities Inc.’s holdings in Mettler-Toledo International were worth $379,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Bank of Montreal Can grew its holdings in shares of Mettler-Toledo International by 27.9% during the 3rd quarter. Bank of Montreal Can now owns 76,303 shares of the medical instruments supplier’s stock worth $46,467,000 after purchasing an additional 16,641 shares during the period. First Hawaiian Bank purchased a new position in shares of Mettler-Toledo International during the 3rd quarter worth $204,000. Raymond James Trust N.A. purchased a new position in shares of Mettler-Toledo International during the 3rd quarter worth $233,000. Nisa Investment Advisors LLC grew its holdings in shares of Mettler-Toledo International by 7.9% during the 3rd quarter. Nisa Investment Advisors LLC now owns 17,558 shares of the medical instruments supplier’s stock worth $10,692,000 after purchasing an additional 1,288 shares during the period. Finally, Oakbrook Investments LLC grew its holdings in shares of Mettler-Toledo International by 22.1% during the 3rd quarter. Oakbrook Investments LLC now owns 2,625 shares of the medical instruments supplier’s stock worth $1,599,000 after purchasing an additional 475 shares during the period. Institutional investors and hedge funds own 93.75% of the company’s stock.
Shares of Mettler-Toledo International stock opened at $668.61 on Thursday. Mettler-Toledo International Inc. has a 12 month low of $500.74 and a 12 month high of $674.05. The stock has a market cap of $16.84 billion, a P/E ratio of 32.90, a PEG ratio of 2.29 and a beta of 1.30. The company has a debt-to-equity ratio of 1.67, a current ratio of 1.42 and a quick ratio of 1.06.
Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, February 7th. The medical instruments supplier reported $6.85 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.11. Mettler-Toledo International had a return on equity of 94.57% and a net margin of 17.46%. The company had revenue of $817.92 million during the quarter, compared to analysts’ expectations of $807.58 million. During the same period last year, the business posted $5.97 EPS. Mettler-Toledo International’s revenue for the quarter was up 5.1% on a year-over-year basis. As a group, equities analysts expect that Mettler-Toledo International Inc. will post 22.6 EPS for the current fiscal year.
MTD has been the subject of a number of research analyst reports. ValuEngine upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Friday, November 16th. Zacks Investment Research upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating and set a $742.00 price target for the company in a report on Tuesday. Bank of America cut Mettler-Toledo International from a “buy” rating to a “neutral” rating and set a $546.04 target price for the company. in a report on Thursday, January 3rd. Finally, Evercore ISI cut Mettler-Toledo International from an “in-line” rating to an “underperform” rating in a report on Thursday, January 3rd. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $615.84.
In other Mettler-Toledo International news, CEO Oliver A. Filliol sold 17,000 shares of the stock in a transaction dated Tuesday, February 12th. The stock was sold at an average price of $666.64, for a total value of $11,332,880.00. Following the sale, the chief executive officer now owns 33,279 shares of the company’s stock, valued at approximately $22,185,112.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider William P. Donnelly sold 2,500 shares of the stock in a transaction dated Monday, November 19th. The shares were sold at an average price of $598.20, for a total value of $1,495,500.00. The disclosure for this sale can be found here. Insiders sold a total of 67,120 shares of company stock worth $43,373,367 in the last ninety days. 4.80% of the stock is owned by corporate insiders.
Mettler-Toledo International Profile
Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; analytical instruments for use in life science; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; and end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries.
Read More: Candlestick
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.